Fylde and Wyre Policies

Click each header to expand its content

Commissioning Policies

Application Amendment Waiver of Policies for the Comm of Appropriate Effective and Priority Health Care 0.4 MB103
Commissioning Policies Introduction Document 89 KB120
Considering Applications For Exceptionality 0.3 MB178
General Policy IFR Decision Making 0.4 MB124
Policy for Assisted Conception Services 0.1 MB15
Policy for Benign Skin Lesion (updated September 2019) 0.2 MB116
Policy for Carpal Tunnel Syndrome updated October 2019 0.2 MB72
Policy for Chalazia Removal 0.2 MB99
Policy for Choice of Service Provide 0.2 MB135
Policy For Commissioning Spinal Injection Radiofrequency Denervation For Low Back Pain 0.6 MB114
Policy for Commissioning Spinal Injections and Radiofrequency Denervation for Low Back Pain 0.4 MB131
Policy for Complementary and Alternative Therapies 88 KB113
Policy for Complex Cases 0.2 MB101
Policy for cosmetic procedures 98 KB7
Policy for Dilatation and Curettage 45 KB88
Policy for Dupuytren's contracture 0.3 MB107
Policy for Endoscopic Procedures on the Knee Joint Cavity 0.2 MB99
Policy for ESWT 86 KB7
Policy for excision of the uterus 0.1 MB96
Policy for ganglia excision 0.2 MB82
Policy for Glucose Monitoring Devices (March 19 amends) 0.3 MB210
Policy for Grommets (updated September 2019) 0.2 MB39
Policy for Gynaecomastia (updated September 2019) 0.2 MB47
Policy for Haemorrhoid surgery 0.2 MB88
Policy for Hip Arthroscopy 42 KB109
Policy for hysteroscopy 0.1 MB50
Policy for insulin pump provision 0.1 MB78
Policy for Low Intensity Pulsed Ultrasound (LIPUS) Therapy (updated January 2020) 0.3 MB19
Policy for Lumbar spine procedures 0.3 MB96
Policy for Male Circumcision 0.2 MB139
Policy for Monitoring and Enforcing CCG Policies 0.1 MB100
Policy for photorefractive surgery 0.1 MB90
Policy for Reversal of Sterilisation 0.1 MB54
Policy for services that are the subject of guidance from NICE 0.1 MB137
Policy for snoring surgery 0.2 MB82
Policy for Specified Expensive Services 0.1 MB99
Policy for Specified Non-clinical issues 0.1 MB106
Policy for Specified Services for which provision in service agreements may be limited 0.2 MB122
Policy for Surgical Release of Trigger Finger (updated September 2019) 0.2 MB56
Policy for testing for Malignant Hyperthermia 0.1 MB126
Policy for Tonsillectomy (updated September 2019) 0.2 MB73
Policy for varicose veins 0.2 MB63
Policy Process map appeals 0.1 MB94
Policy Spinal Cord Stimulation 38 KB147
Policy subacromial decompression 0.2 MB80
Policy_for_Assisted_Conception_Services 83 KB3
Policy_for_breast_implant_removal_and_replacement 51 KB3
Policy_for_breast_implant_removal_and_replacement 82 KB7
Policy_for_cosmetic_procedures 62 KB3
Policy_for_ESWT 55 KB5
Statement Of Principles 0.3 MB95

Commissioning Policy summaries

Corporate Policies

Information Governance

Medicines Optimisation

Azelastine Fluticasone (Dymista) Nasal Spray 0.1 MB190
Bazedoxifene for oestrogen deficiency symptoms 0.3 MB124
Botulinum Toxin A for Spasticity and Contracture of the joint 0.3 MB132
Brimonidine For Erythema Of Rosacea 0.1 MB118
Certolizumab For Psoriatic Arthritis 0.1 MB101
Co-Proxamol For pain management 0.3 MB244
Co-trimoxazole for the prophylaxis of pneumocystis jirovecii (pneumocystis carinii) infections 0.3 MB127
Co-trimoxazole Prophylaxis of Primary and Secondary Spontaneous Bacterial Peritonitis (SBP) 0.1 MB125
Colesevelam (Cholestagel® ) For combination or monotherapy for familial hypercholesterolaemia 0.3 MB118
Colistimethate sodium/Colistin sulfomethate sodium (Colomycin® ) For non-Cystic Fibrosis in Patients with Bronchiectasis Colonised with Pseudomonas Aeruginosa 0.2 MB91
Conditions for which over the counter items should not routinely be prescribed in primary care 0.9 MB239
Daily selective serotonin re-uptake inhibitors (SSRIs) for the treatment of premature ejaculation (PE) 0.2 MB86
Dapoxetine for the treatment of premature ejaculation (PE) 0.2 MB98
Denosumab for GIO 0.2 MB67
Dulaglutide for the treatment of Type II Diabetes Mellitus in adults 0.3 MB134
Eflornithine-cream-for-facial-hirsutism 0.2 MB124
Eltrombopag For Thrombocytopenia In Hepatitis C 0.1 MB80
Eslicarbazepine For Focal Seizures 0.1 MB106
Evolocumab (Repatha SureClick® ) For prevention of cardiac events in patients with CHD and a history of ACS, in combination with a statin 0.1 MB116
Ferric Maltol 30mg Capsules in Adults for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease 0.3 MB120
Fluorouracil-5-cream-for-basal-cell-carcinomas 0.1 MB80
Gluten-Free-Food-Products 0.3 MB125
Guanfacine-for-ADHD 0.3 MB103
Imiquimod-5-cream-for-basal-cell-carcinomas 0.2 MB103
Insulin Degludec And Liraglutide 0.2 MB102
Insulin-Aspart-for-Diabetes-Mellitus 0.3 MB115
Insulin-Degludec-for-DM 0.3 MB117
Insulin-Detemir-for-DM 0.2 MB88
Insuline-Glargine-for-T1DM 0.3 MB96
Insuline-Glargine-for-T2DM 0.3 MB98
Invicorp-injection-for-erectile-dysfunction 0.3 MB133
Ivermectin-cream-for-rosacea 0.3 MB112
JIA Policy For Adults (Version 1.0) 0.2 MB85
Lamotrigine-for-trigeminal-neuralgia 0.3 MB109
Lamotrigine-for-trigeminal-neuralgia 2 0.3 MB130
Levonorgestrel 13.5mg IUD 0.3 MB90
Lidocaine Plasters For PHN 0.2 MB101
Lidocaine-plasters-for-unlicensed-indications 0.3 MB177
Liothyronine-for-refractory-hypothyroidism 0.2 MB142
Liraglutide-for-obesity 0.3 MB109
Lisdexamfetamine-for-ADHD-in-adults 0.3 MB124
Lisdexamfetamine-for-ADHD-update 0.3 MB102
Lurasidone-for-Schizophrenia 0.3 MB126
Magnaspartate For Hypomagnesaemia 0.3 MB206
Metformin-for-reductionof-risk-or-delay-type-2-daibetes 0.2 MB94
Metformin-for-reductionof-risk-or-delay-type-2-daibetes 2 0.2 MB78
Midazolam-Epistatus-for-seizures 0.2 MB134
Opicapone-for-Parkinsons-disease-v2 0.5 MB129
Ospemifene for VVA 0.2 MB138
Oxycodone-Naloxone-for-Restless-legs 0.3 MB91
Paravit-CF-for-dietary-management-of-patients-with-cystic-fibrosis 0.2 MB329
Patiromer-for-hyperkalaemia 0.3 MB99
Patiromer-for-hyperkalaemia 2 0.3 MB118
Phosphodiesterase Type-5 Inhibitors 0.2 MB89
Pitolisant-for-Narcolepsyv2 0.3 MB103
Policy On Brand Inhaler Prescribing 0.3 MB144
Probiotics And VSL 0.3 MB103
Relvar Ellipta for COPD and asthma in adults 63 KB86
Rituximab-for-AIHA 0.4 MB121
Rituximab-for-ITP 0.4 MB101
Rivaroxaban-10mg-for-DVT-and-PE-and-extended-use 0.1 MB107
Safinamide-for-Parkinsons-disease 0.3 MB128
Second Line Anti-TNF For PsA 0.2 MB107
Second-generation-LA-antipsychotics 0.3 MB122
Secukinumab-for-Palmoplantar-psoriasis 0.3 MB94
Secukinumab-for-Palmoplantar-psoriasis 2 0.3 MB97
Semaglutide for type 2 DM 0.2 MB70
Silk Garments For Eczema And Dermatitis 0.2 MB92
Simbrinza for chronic open angle glaucoma 0.1 MB83
Sodium Oxybate for Narcolepsy with Cataplexy 0.3 MB116
Spironolactone For Acne 0.1 MB128
Subcutaneous Depot Medroxyprogesterone Acetate 0.1 MB99
Tadalafil daily 0.3 MB134
Tapentadol for neuropathic pain in non-palliative care 0.4 MB116
Tapentadol for non-specific pain 0.2 MB102
Testosterone For Female Sexual Dysfunction 0.1 MB77
Tiotropium For Asthma 0.2 MB86
Trelegy inhaler for COPD 0.3 MB128
Trimbow inhaler for COPD 0.4 MB124
Trimbow-inhaler-for-COPD 0.4 MB6
Ulipristal acetate for uterine fibroids 0.5 MB108
Umeclidinium For COPD 0.2 MB77
Vedolizumab For Crohn's Disease 0.2 MB67
Vitamins (inc Renavit) For Dialysis 0.3 MB131
Waterproof Cast Cover Policy 0.1 MB212
Xonvea for nausea and vomiting in pregnancy 0.1 MB72

Last updated on 17 September 2019 at 15:48 by communications manager